These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16585512)

  • 1. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
    Vajkoczy P; Knyazev P; Kunkel A; Capelle HH; Behrndt S; von Tengg-Kobligk H; Kiessling F; Eichelsbacher U; Essig M; Read TA; Erber R; Ullrich A
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5799-804. PubMed ID: 16585512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
    Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
    Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
    Hutterer M; Knyazev P; Abate A; Reschke M; Maier H; Stefanova N; Knyazeva T; Barbieri V; Reindl M; Muigg A; Kostron H; Stockhammer G; Ullrich A
    Clin Cancer Res; 2008 Jan; 14(1):130-8. PubMed ID: 18172262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.
    Wang Y; Guan G; Cheng W; Jiang Y; Shan F; Wu A; Cheng P; Guo Z
    BMC Cancer; 2018 May; 18(1):599. PubMed ID: 29843637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.
    Yan J; Xu C; Li Y; Tang B; Xie S; Hong T; Zeng E
    J Cell Mol Med; 2019 Aug; 23(8):5518-5531. PubMed ID: 31240814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles for the receptor tyrosine kinase axl in tumor formation.
    Holland SJ; Powell MJ; Franci C; Chan EW; Friera AM; Atchison RE; McLaughlin J; Swift SE; Pali ES; Yam G; Wong S; Lasaga J; Shen MR; Yu S; Xu W; Hitoshi Y; Bogenberger J; Nör JE; Payan DG; Lorens JB
    Cancer Res; 2005 Oct; 65(20):9294-303. PubMed ID: 16230391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AXL is a potential target for therapeutic intervention in breast cancer progression.
    Zhang YX; Knyazev PG; Cheburkin YV; Sharma K; Knyazev YP; Orfi L; Szabadkai I; Daub H; Kéri G; Ullrich A
    Cancer Res; 2008 Mar; 68(6):1905-15. PubMed ID: 18339872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.
    Tai KY; Shieh YS; Lee CS; Shiah SG; Wu CW
    Oncogene; 2008 Jul; 27(29):4044-55. PubMed ID: 18345028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
    Holland SJ; Pan A; Franci C; Hu Y; Chang B; Li W; Duan M; Torneros A; Yu J; Heckrodt TJ; Zhang J; Ding P; Apatira A; Chua J; Brandt R; Pine P; Goff D; Singh R; Payan DG; Hitoshi Y
    Cancer Res; 2010 Feb; 70(4):1544-54. PubMed ID: 20145120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
    Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
    Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of axl in lung adenocarcinoma and correlation with tumor progression.
    Shieh YS; Lai CY; Kao YR; Shiah SG; Chu YW; Lee HS; Wu CW
    Neoplasia; 2005 Dec; 7(12):1058-64. PubMed ID: 16354588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC
    Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.
    Yen SY; Chen SR; Hsieh J; Li YS; Chuang SE; Chuang HM; Huang MH; Lin SZ; Harn HJ; Chiou TW
    Oncogene; 2016 Apr; 35(17):2156-65. PubMed ID: 26257061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human anti-AXL monoclonal antibody attenuates tumour cell migration.
    Duan Y; Luo L; Qiao C; Li X; Wang J; Liu H; Zhou T; Shen B; Lv M; Feng J
    Scand J Immunol; 2019 Aug; 90(2):e12777. PubMed ID: 31075180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AXL is an oncotarget in human colorectal cancer.
    Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F
    Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
    Bansal N; Mishra PJ; Stein M; DiPaola RS; Bertino JR
    Oncotarget; 2015 Jun; 6(17):15321-31. PubMed ID: 26036314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
    Leconet W; Larbouret C; Chardès T; Thomas G; Neiveyans M; Busson M; Jarlier M; Radosevic-Robin N; Pugnière M; Bernex F; Penault-Llorca F; Pasquet JM; Pèlegrin A; Robert B
    Oncogene; 2014 Nov; 33(47):5405-14. PubMed ID: 24240689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.